A Pilot Study on the Use of Methoxyflurane (Penthrox®) for Pain Control in the Emergency Department

PHASE3CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 28, 2020

Primary Completion Date

November 21, 2020

Study Completion Date

November 21, 2020

Conditions
Acute Traumatic Pain
Interventions
DRUG

Methoxyflurane

Each patient in the methoxyflurane group will use one Penthrox inhaler under supervision of trained personnel. After priming the inhaler with 3 mL of methoxyflurane, patient is instructed to inhale through the mouthpiece to obtain analgesia, and then exhale back into the mouthpiece so that any unmetabolized methoxyflurane can be adsorbed by activated charcoal chamber. First few breaths should be gentle and then breathe normally through Inhaler. Onset of pain relief is rapid and occurs after 6-10 inhalations. If stronger analgesia is required, patient can cover the diluter hole with a finger during inhalation. Patients are able to titrate the amount of methoxyflurane inhaled and should be instructed to inhale intermittently to achieve adequate pain control.

DRUG

Ketorolac

Each patient in the ketorolac group will receive one dose of 30mg intramuscular ketorolac injected at gluteal muscle by nursing staff as usual daily practice.

Trial Locations (1)

Unknown

Hospital Authority, Hong Kong

All Listed Sponsors
lead

Hospital Authority, Hong Kong

OTHER_GOV

NCT04618497 - A Pilot Study on the Use of Methoxyflurane (Penthrox®) for Pain Control in the Emergency Department | Biotech Hunter | Biotech Hunter